SCHEMBL5744526

SCHEMBL5744526

Cc1ccccc1C1C(N)CCN1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.39
HSP90AA1 P07900 4/20 0.38
HSP90AB1 P08238 4/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 1/20 0.37
ITGB3 P05106 1/20 0.36
ITGB1 P05556 1/20 0.36
ITGAV P06756 1/20 0.36
ITGA5 P08648 1/20 0.36
ITGA4 P13612 1/20 0.36
MAOB P27338 1/20 0.36
BRD4 O60885 1/20 0.36
MCHR1 Q99705 1/20 0.36
HSD11B1 P28845 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
HTR2C P28335 1/20 0.35
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5744524 1.00 RIPK1 (0.39) RIPK1HSP90AA1HSP90AB1GAATSHR
SCHEMBL5747935 0.92 HSP90AA1 (0.44) RIPK1HSP90AA1HSP90AB1ALDH1A1ITGB3
SCHEMBL6310123 0.92 HSP90AA1 (0.44) RIPK1HSP90AA1HSP90AB1ALDH1A1ITGB3
SCHEMBL6318100 0.80 ITGB3 (0.38) RIPK1HSP90AA1HSP90AB1GAATSHR
SCHEMBL6318104 0.80 ITGB3 (0.38) RIPK1HSP90AA1HSP90AB1GAATSHR
SCHEMBL5746786 0.78 HSP90AA1 (0.43) RIPK1HSP90AA1HSP90AB1ALDH1A1ITGB3
SCHEMBL5746789 0.78 HSP90AA1 (0.43) RIPK1HSP90AA1HSP90AB1ALDH1A1ITGB3
SCHEMBL2800961 0.77 BRD4 (0.40) RIPK1HSP90AA1HSP90AB1ITGB3ITGB1
SCHEMBL6317365 0.76 HSP90AA1 (0.44) RIPK1HSP90AA1HSP90AB1ITGB3ITGB1
SCHEMBL17509670 0.76 OPRD1 (0.43) RIPK1HSP90AA1HSP90AB1ITGB3ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638935-A1 NK1 ANTAGONIST Pfizer Products Inc. (US) 2006-03-29 EP claimed
US-20050043354-A1 NK1 antagonist PFIZER INC 2005-02-24 US claimed
WO-2004110996-A1 NK1 ANTAGONIST PFIZER PRODUCTS INC. (US) 2004-12-23 WO claimed
US-20050043354-A1 NK1 antagonist PFIZER INC 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043354-A1 NK1 antagonist TACR2, TACR1, TAC3 RIPK1 2280/4885HSP90AA1 3787/4885HSP90AB1 3339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.